Drug Testing Locations - Laurel Lake, NJ

Drug Testing in Laurel Lake, NJ

Laurel Lake, New Jersey Statistics

In 2020, Cumberland County, including Laurel Lake, reported 403 drug overdose deaths.

Laurel Lake, in Cumberland County, saw a 29% increase in drug-related arrests from 2019 to 2021.

The rate of opioid prescriptions in Cumberland County, including Laurel Lake, was 44.2 per 100 residents in 2021.

Substance abuse treatment admissions in Cumberland County, covering Laurel Lake, increased by 15% in 2022.

In 2022, 55% of drug-related emergency room visits in Cumberland County involved heroin.

A survey found that 64% of residents in Cumberland County, including Laurel Lake, viewed opioid abuse as a major problem in 2021.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Laurel Lake, NJ & Drug Testing Policies

In Laurel Lake, NJ, employers are increasingly focused on maintaining a drug-free workplace. Cumberland County businesses follow guidelines set forth by the U.S. Department of Labor, which supports employers in creating comprehensive drug testing policies. These policies often include pre-employment testing, reasonable suspicion testing, and random testing to ensure employee safety.

Additionally, many companies in the area work with the Substance Abuse and Mental Health Services Administration to provide educational resources and support systems for employees struggling with addiction. Employers recognize the importance of a supportive approach and provide Employee Assistance Programs (EAPs) to help workers seek the necessary help without fear of job loss.

Government Efforts with Drug Problems in Laurel Lake, NJ

To combat drug abuse in Laurel Lake, NJ, government initiatives have been rolled out at various levels. The New Jersey Office of the Attorney General has launched programs to lower opioid prescription rates and increase addiction support services within Cumberland County, where Laurel Lake is situated. These initiatives focus on both prevention and rehabilitation.

Local efforts include the County Prosecutor's Office running educational workshops and coordinating with the Department of Human Services to provide resources for residents. Further, the state’s Department of Health collaborates with community organizations to amplify harm reduction measures, such as the distribution of naloxone kits. These efforts signify a multi-faceted approach to tackling the drug crisis locally.

Local Drug Busts & News in Laurel Lake, NJ

Recently, Laurel Lake, NJ, has seen several significant drug-related events. In 2023, local law enforcement successfully executed a major drug bust, seizing large quantities of heroin and cocaine, which marked a critical victory against substance distribution in Cumberland County. These efforts were coordinated by the Drug Enforcement Administration in partnership with local police.

Community engagement has been a key focus as well. Town hall meetings, organized by the Cumberland County Government, have invited residents to participate in discussions about ongoing drug issues and how to address them. These events serve both awareness and prevention objectives while fostering a proactive community response.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Laurel Lake, NJ. Trusted by employers nationwide for accurate results and exceptional service.

New Jersey DOT/Non DOT Physicals

New Jersey Vision Tests

New Jersey Audiograms

New Jersey Respirator Fit Tests

New Jersey Lift Tests

New Jersey Background Checks

Clinical Testing Services

TB Testing in NJ

Diabetes Testing in NJ

Infectious Disease Testing in NJ

Sickle Cell Anemia Testing in NJ

Women/Men's Health Testing in NJ

Resources & Citations

New Jersey Attorney General

NJ 211 Substance Abuse Assistance

Recovery.org NJ

Cape May County Health Department

Cumberland County DRCC

South Jersey Recovery

CCOHS Drug Rehab

NJ Prescription Monitoring Program

Drug Testing Near Laurel Lake, NJ

Seabrook Farms, NJ

Dennisville, NJ

Newfield, NJ

Woodbine, NJ

Buena, NJ

Bridgeton, NJ

Dorothy, NJ

Rosenhayn, NJ

Vineland, NJ

Belleplain, NJ

Fairton, NJ

Leesburg, NJ

Port Norris, NJ

Millville, NJ

Frequently Asked Questions

Customer Reviews